Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines - Lodi, Sara; Phillips, Andrew; Touloumi, Giota; Geskus, Ronald; Meyer, Laurence; Thiébaut, Rodolphe; Pantazis, Nikos; del Amo, Julia; Johnson, Anne M.; Babiker, Abdel; Porter, Kholoud (Clinical infectious diseases, 2011)
Keywords: Adult; AIDS; Antiretrovirals; Biological and medical sciences; Carts; CD4 Lymphocyte Count; Cohort Studies; Confidence interval; Drug Administration Schedule; Drug Therapy, Combination; Early Diagnosis; Europe - epidemiology; Female; Follow-Up Studies; HIV; HIV infections; HIV Infections - drug therapy; HIV Infections - epidemiology; HIV Infections - immunology; HIV Infections - virology; HIV seropositivity; HIV Seropositivity - drug therapy; HIV Seropositivity - immunology; HIV-1 - immunology; HIV/AIDS; Human viral diseases; Humans; Immunodeficiencies; Immunodeficiencies. Immunoglobulinopathies; Immunopathology; Infectious diseases; Interval estimators; Linear Models; Male; Medical sciences; Men; Middle Aged; Mortality; Practice Guidelines as Topic; Risk Factors; Sexual Behavior; Time Factors; United States - epidemiology; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; United States; Europe; Infection; Virus; Numeration; Immunopathology; Treatment; Viral disease; Retroviridae; AIDS; Human immunodeficiency virus; Immune deficiency; Lentivirus; Recommendation